Actuate Therapeutics Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss CRS Q1 2026 Earnings EPS Exceeds Expectations Amid Cautious Market Response Conduent Q1 2026 Earnings EPS Surprises Significantly Above Estimates Stock Surges MCRI Q1 2026 Earnings Strong EPS Surprise Driven by Operational Efficiency BLSH Q1 2026 Earnings EPS Misses Estimates Stock Declines 217 Mattel Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Control